In the DEEP Trial, 62.4% of patients with Advanced Afib* who underwent hybrid ablation combined with left atrial appendage exclusion using AtriClip® remained free from atrial arrhythmias** at 2 years follow-up.​

*Persistent or long-standing persistent Afib.​​
**Effectiveness was freedom from Afib, atrial flutter, atrial tachycardia (>30 sec); absent new/increased dose of previously failed class I/III anti-arrhythmic drugs.​

<a href='https://www.linkedin.com/feed/hashtag/?keywords=Epeeps&highlightedUpdat…; target='_blank'>#Epeeps</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=Afib&highlightedUpdateU…; target='_blank'>#Afib</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=Cardiac&highlightedUpda…; target='_blank'>#Cardiac</a>

Hear from cardiothoracic surgeon Dr. John Ofenloch as he shares his experience using the EnCompass® Clamp and what sets it apart in surgical ablation.​

Discover more about EnCompass: <a href="https://t.co/ZLdcc2BNY6&quot; target="_blank">https://t.co/ZLdcc2BNY6</a&gt; ​

<a href="https://twitter.com/hashtag/Ablation?src=hashtag_click&quot; target="_blank">#Ablation</a> <a href="https://twitter.com/hashtag/CardioTwitter?src=hashtag_click&quot; target="_blank">#CardioTwitter</a>

Hear from cardiothoracic surgeon Dr. John Ofenloch as he shares his experience using the EnCompass® Clamp and what sets it apart in surgical ablation.​

Discover more about EnCompass: <a href="https://okt.to/38euEq&quot; target="_blank">https://okt.to/38euEq</a&gt;

<a href='https://www.linkedin.com/feed/hashtag/?keywords=Ablation&highlightedUpd…; target='_blank'>#Ablation</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=CardiacSurgery&highligh…; target='_blank'>#CardiacSurgery</a>

Enrollment is closed for the largest randomized trial in cardiac surgery! The LeAAPS Trial will follow 6,500 patients over 5 years to study whether AtriClip® devices for LAAE can reduce stroke risk in high-risk patients without a history of Afib. Learn more:

Enrollment is now complete for the largest randomized trial in cardiac surgery—6,500 patients strong!

The LeAAPS Trial will follow these patients over the next 5 years to evaluate whether AtriClip® devices for left atrial appendage exclusion (LAAE) can reduce stroke risk in high-risk patients without a history of Afib.

This simple addition to cardiac procedures could have a major impact.

Learn more about the trial here: <a href="https://okt.to/DBiQcy&quot; target="_blank">https://okt.to/DBiQcy</a&gt;
<a href='https://www.linkedin.com/feed/hashtag/?keywords=ClinicalTrial&highlight…; target='_blank'>#ClinicalTrial</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=Afib&highlightedUpdateU…; target='_blank'>#Afib</a> <a href='https://www.linkedin.com/feed/hashtag/?keywords=Stroke&highlightedUpdat…; target='_blank'>#Stroke</a>

This is what can happen when focus, urgency, and a shared belief in our mission come together. Thank you for the commitment from so many <a href="https://twitter.com/AtriCure&quot; target="_blank">@AtriCure</a> professionals, physicians and our worldwide PIs for helping to transform care for patients.

As part of a multimodal approach, Cryo Nerve Block offers a non-opioid pain management solution that can last for several months.​

Dr. Daniel Miller share his experience and insights on cryoNB.​

Discover more: <a href="https://t.co/5XNCWIyK7T&quot; target="_blank">https://t.co/5XNCWIyK7T</a&gt; ​

<a href="https://twitter.com/hashtag/PainManagement?src=hashtag_click&quot; target="_blank">#PainManagement</a>

As part of a multimodal approach, Cryo Nerve Block offers a non-opioid pain management solution that can last for several months.​

Dr. Daniel Miller MD share his experience and insights on cryoNB.​

Discover more: <a href="https://okt.to/Wun93x&quot; target="_blank">https://okt.to/Wun93x</a&gt; ​

The <a href="https://twitter.com/HCAFLHealthcare&quot; target="_blank">@HCAFLHealthcare</a> team completed their first EPi-Ease™ case! ​

Congratulations to Dr. <a href="https://twitter.com/dkenigsberg&quot; target="_blank">@dkenigsberg</a> on this milestone moment. With increased safety, the EPi-Ease device is providing a safer approach to an epicardial VT ablation.​

Learn more: <a href="https://t.co/nt42K4HLbg&quot; target="_blank">https://t.co/nt42K4HLbg</a&gt;

The HCA Florida Westside Hospital team completed their first EPi-Ease™ case! ​

Congratulations to Dr. David N. Kenigsberg, MD, FACC, FHRS on this milestone moment. With increased safety measures in place, the EPi-Ease epicardial access device is providing a safer approach to an epicardial ventricular tachycardia (VT) ablation.​

Learn more: <a href="https://okt.to/GUV1xQ&quot; target="_blank">https://okt.to/GUV1xQ</a&gt; ​

<a href='https://www.linkedin.com/feed/hashtag/?keywords=Epeeps&highlightedUpdat…; target='_blank'>#Epeeps</a>